[1] SNIJDERS R A H, BROM L, THEUNISSEN M, et al. Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis[J]. Cancers, 2023, 15(3): 591.
[2] KWON J H. Overcoming barriers in cancer pain management[J]. J Clin Oncol, 2014, 32(16): 1727-1733.
[3] ROTTNEK F. Chasing the pendulum: the past, present, and future of opioids and older adults[J]. Innov Aging, 2025, 9(6): igaf040.
[4] AL-OBAIDI M, KOSMICKI S, HARMON C, et al. Pain among older adults with gastrointestinal malignancies- results from the cancer and aging resilience evaluation (CARE) Registry[J]. Support Care Cancer, 2022, 30(12): 9793-9801.
[5] BESSEDE A, MARABELLE A, GUÉGAN J P, et al. Impact of acetaminophen on the efficacy of immunotherapy in cancer patients[J]. Ann Oncol, 2022, 33(9): 909-915.
[6] MAGEE D J, JHANJI S, POULOGIANNIS G, et al. Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence[J]. Br J Anaesth, 2019, 123(2): e412-e423.
[7] DERRY S, BELL R F, STRAUBE S, et al. Pregabalin for neuropathic pain in adults[J]. Cochrane Database Syst Rev, 2019, 1(1): CD007076.
[8] FINNERUP N B, ATTAL N, HAROUTOUNIAN S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis[J]. Lancet Neurol, 2015, 14(2): 162-173.
[9] CORLI O, FLORIANI I, ROBERTO A, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV ‘real life’ trial on the variability of response to opioids[J]. Ann Oncol, 2016, 27(6): 1107-1115.
[10] 中国抗癌协会肿瘤整体评估专业委员会. 阿片类药物不良反应综合防治专家共识(2024年版)[J]. 中国肿瘤临床, 2024, 51(15): 757-763.
[11] ABOU-KASSEM D, KURITA G P, SJØGREN P, et al. Long-term opioid treatment and endocrine measures in patients with cancer-related pain: a systematic review[J]. Scand J Pain, 2022, 22(3): 421-435.
[12] WANG D D, MA T T, ZHU H D, et al. Transdermal fentanyl for cancer pain: trial sequential analysis of 3406 patients from 35 randomized controlled trials[J]. J Cancer Res Ther, 2018, 14(Suppl 1): S14-S21.
[13] 杜美慧, 刘越, 曾永芬, 等. 美沙酮按需转换法治疗癌痛的临床研究[J]. 中国疼痛医学杂志, 2024, 30(3): 189-195.
[14] MERCADANTE S, LO CASCIO A, ADILE C, et al. Maddalena Opioid Switching Score in patients with cancer pain[J]. Pain, 2023, 164(1): 91-97.
[15] DAVIS M P, DAVIES A, MCPHERSON M L, et al. Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline[J]. Support Care Cancer, 2025, 33(3): 243.
[16] RUANO A, GARCÍA-TORRES F, GÁLVEZ-LARA M, et al. Psychological and non-pharmacologic treatments for pain in cancer patients: a systematic review and meta-analysis[J]. J Pain Symptom Manage, 2022, 63(5): e505-e520.
[17] 李淏, 李沛瑾, 刘婷婷, 等. 癌性疼痛中西医结合诊疗指南[J]. 中国全科医学, 2025, 28(30): 3729-3740.
[18] HE Y, GUO X, MAY B H, et al. Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis[J]. JAMA Oncol, 2020, 6(2): 271-278.
[19] FENG B, HU X, LU W W, et al. Are mindfulness treatments effective for pain in cancer patients? A systematic review and meta-analysis[J]. Eur J Pain, 2022, 26(1): 61-76.
[20] WARTH M, ZÖLLER J, KÖHLER F, et al. Psychosocial interventions for pain management in advanced cancer patients: a systematic review and meta-analysis[J]. Curr Oncol Rep, 2020, 22(1): 3.
[21] ALZOUBI Z, LOMAN B R. Nutrition interventions in the treatment of gastrointestinal symptoms during cancer therapy: a systematic review and meta-analysis[J]. Adv Nutr, 2025, 16(9): 100485.
[22] MERCADANTE S, CANDIDO K, STAATS P, et al. Spinal analgesia in cancer pain management-MASCC general practice recommendations[J]. Support Care Cancer, 2025, 33(8): 674.
[23] SCHUMACHER K L, PLANO CLARK V L, RABOW M W, et al. The experience of complex pain dynamics in oncology outpatients: a longitudinal qualitative analysis[J]. Cancer Nurs, 2021, 44(2): 136-144. |